APPS 0  |  CONTACT US  |  CAREERS  |  LOCATE US  |  DOWNLOADS  |  BLOG
CONNECT WITH US ON
Financial Services | Broking & Distribution | Institutional Equities | Private Wealth Management | Investment Banking | Private Equity | Asset Management | Commodities | Home Finance
Broking & Distribution > Markets > Company Information > News

Aurobindo Pharma Ltd

BSE Code : 524804   |   NSE Symbol : AUROPHARMA   |   ISIN : INE406A01037
OVERVIEW INFORMATION FINANCIALS COMPANY NEWS CORPORATE ACTIONS
 
Aurobindo Pharma to hold board meeting  20-Oct-2014 | 10:49
Aurobindo Pharma will hold a meeting of the Board of Directors of the Company on 6 November 2014, to consider the Un-Audited Financial Results of the Company for the quarter and half year ended 30 September 2014 (Q2).Powered by Capital Market - Live News...
Aurobindo Pharma allots equity shares   07-Oct-2014 | 16:25
Aurobindo Pharma announced that the Company has made allotment of 7,700 Equity Shares of Re. 1/- each of the Company at a premium of Rs. 186.40 per equity share under ESOP-2006 of the Company on 07 October 2014. Consequent to the allotment the paid up share capital of the Company has increased from 29,14,57,021 Equity Shares of Re. 1/- each to 29,14,64,721 Equity Shares of Re. 1/- each.Po...
Aurobindo Pharma gets final approval for Amoxicillin for Oral Suspension  16-Sep-2014 | 16:16
Aurobindo Pharma announced that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Amoxicillin for Oral Suspension USP 125mg/5mL and 250mg/5mL (ANDA 204030).Amoxicillin for Oral Suspension USP 125mg/5mL and 250mg/5mL is the generic equivalent to the reference listed drug product (RLD), Amoxicillin for Oral Suspension, 125mg/5 mL and ...
Board of Aurobindo Pharma approves interim dividend   08-Aug-2014 | 11:25
Aurobindo Pharma announced that the Board of Directors of the Company at its meeting held on 07 August 2014, inter alia, has considered & approved Interim dividend of 150% i.e. Rs.1.50/- (Rupee one and paise fifty only) per share of Re. 1/- each on the equity share capital of the Company for the year 2014-15.The Interim Dividend will be paid on or before 05 September 2014.Powered by
  Company Information :   Company List A-Z  |   Snapshot  |   Volume Chart  |   Investor Returns  |   Score Board  |   Company Peer Comparison  |   Background  |   Board of Directors  |   Quarterly Results  |   Balance Sheet  |   Share Holding Pattern  |   MF Holdings  |   Profit & Loss  |   Key Ratios / Cash Flow  |   Company News  |   Bonus / Split / Rights  |   Dividend / Book Closure  |   Capital Structure  |   Insider Trading History  |   Top Companies By MCAP  |   Top Dividend Yield  
  Equity Market       Derivatives       Mutual Funds       Commodities       Currencies       News       IPO    
Login
Login Open An Account Trade Now
Open a FREE Trading Account
Open an Account
Name :
Mobile :
Email :
State :
City :
Interested in
*Terms & Conditions
Financial Services Products & ServicesBusiness PartnerMarket InfoResearchQuick LinksBusinesses
Stocks   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Mutual Funds   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Commodities   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Disclaimer | Additional Disclaimer for U.S. Persons  | Feedback | Locate Us | Do Not Call Form
Motilal Oswal Securities Ltd. (MOSL) Member of NSE, BSE and MCX-SX
Regd Office: Motilal Oswal Tower, Rahimtullah Sayani Road, Opposite Parel ST Depot, Prabhadevi, Mumbai-400025; CIN no.: U65990MH1994PLC079418; Tel No.: 022 3980 4263
Correspondence Office Address: Motilal Oswal Securities Limited, Palm Spring Centre, 2nd Floor, Palm Court Complex, New Link Road, Malad (West) Mumbai – 400064.; Tel No.: 022 3080 1000

Customer having any query / feedback / clarification may write to query@motilaloswal.com
In case of grievances for Securities Broking write to grievances@motilaloswal.com, for DP to dpgrievances@motilaloswal.com, for Commodity Broking to commoditygrievances@motilaloswal.com

Attention Investors "Prevent unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of Investors"
Registration Nos: NSE(Cash) INB231041238; NSE(F&O): INF231041238; NSE(CD): INE231041238; BSE(Cash): INB011041257; BSE(F&O) INF011041257; BSE(CD); MCX-SX (Cash) : INB261041231; MCX-SX (F&O): INF261041231; MCX-SX (CD): INE261041231; CDSL: IN-DP-CDSL-09-99; NSDL: IN-DP-NSDL-152-2000; AMFI:ARN 17397. PMS: INP000000670; PMS & Mutual Funds are offered through Motilal Oswal Asset Management Company Ltd(MOAMC) which is group company of MOSL. PMS (Regn No. INP000004409) is offered through Motilal Oswal Wealth Management Ltd. (MOWML) which is a group company of MOSL. Motilal Oswal Commodities Broker Pvt Ltd. (MOCBPL) member of MCX, NCDEX and NCDEX Spot. MCX Member ID 29500, NCDEX-NCEDX-CO-04-00114, NCDEX Spot Exchange Limited 10014. FMC Unique membership code: MCX: MCX/TCM/CORP/0725, NCDEX: NCDEX/TCM/CORP/0033, Commodity Services are offered through MOCBPL which a group company of Motilal Oswal Securities Ltd. Motilal Oswal Securities Ltd is a distributor of Mutual Fund & IPOs. Investment in Securities is subject to market risk.
Motilal Oswal Securities International Pvt Limited CRD-164319 SEC - 08-69093
Copyright © 2014 MOSL. All Rights Reserved. Market Data provided by C-MOTS Infotech (ISO 9001:2008 Certified)

Site best viewed in IE 7.0+, Mozila Firefox 3.0+ and Google Chrome at 1024 x 768 pixels resolution
GET QUOTES    RESEARCH REPORT  
Our research reports can be searched based on companies covered (COM), sectors covered (SEC) or report names (RPT). Type any three characters of your query to see a search list.